OraSure Technologies, Inc.

OraSure Technologies, Inc. is a medical device company based in Bethlehem, Pennsylvania, founded in 1988. The company focuses on developing, manufacturing, and marketing oral fluid diagnostic products and specimen collection devices. It specializes in rapid, non-invasive testing solutions primarily for infectious diseases and substance abuse. OraSure's product lineup includes diagnostic tests for HIV, Hepatitis C, Ebola, Zika virus, and influenza types A and B. Its flagship product, the OraQuick® test, is the first FDA-approved over-the-counter, at-home HIV test, providing results from an oral swab in just 20 minutes. The company also offers immunoassay tests and reagents for insurance risk assessment and forensic toxicology, as well as cryosurgical products for removing warts and benign skin lesions. OraSure serves a wide range of customers, including clinical laboratories, hospitals, clinics, and government agencies across the Americas, Europe, and the Asia-Pacific region. The company has expanded its capabilities through strategic acquisitions and investments, enhancing its offerings in molecular collection and testing solutions.

• Employees 510
• Founded 1987
• Annual Revenue $185827000
• Total Funding $21339527